Physician profile
David Sprouse
NPI 1528256807
$2,448.81
in general payments reported to CMS, 2019-2025
17 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $89.95 · 2022: $405 · 2023: $768 · 2024: $620 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,944 · Education: $9.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.36 |
| Education | $9.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.21 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $358.96 | 2022-2025 | |
| Janssen Biotech, INC. | $317.86 | 2021-2023 | Tremfya, Simponi, Simponi Aria |
| Amgen INC. | $295.95 | 2022-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $113.34 | 2022-2025 | Dupixent |
| Lilly USA, LLC | $95.24 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $87.56 | 2022-2024 | Cimzia, Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.81 | 2022-2025 | Spevigo |
| Sun Pharmaceutical Industries INC. | $78.12 | 2022-2025 | Ilumya |
| Genzyme Corporation | $67.24 | 2024-2025 | |
| Pfizer INC. | $58.49 | 2022-2024 | |
| Organon LLC | $49.19 | 2025 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $37.21 | 2024 | Sotyktu |
| Incyte Corporation | $35.15 | 2022-2023 | Opzelura |
| Dermavant Sciences, INC. | $33.31 | 2023 | Vtama |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $19.78 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sprouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.